Clinical Trials Browser

Phase 2 × Hematologic Diseases × Erlotinib Hydrochloride × Clear all

NCT00977548 2013-09-16

Erlotinib Study for Myelodysplastic Syndrome (MDS)

Phase 2 Completed

39 enrolled 10 charts

MyeloidOther hematologic neoplasm

Hematologic Diseases, Leukemia, Myelodysplastic Syndromes